Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 617-779-3 | CAS number: 85940-94-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In a dermal sensitization study with DESMODUR BL 3175 in propylene glycol, performed according to the OECD 406 guideline, in compliance with GLP dermal reactions were observed in more than 30% of the animals tested for the three concentrations challenged. Thus DESMODUR BL 3175 is classified as sensitising to the skin according to the criteria of the Annex VI to the Directive 67/548/EC and to the criteria of the Annex I to the CLP Regulation N° (1272/2008).
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vitro
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Well-conducted study according to guideline, GLP, deviation: only 12 instead of 20 animals in the treatment group
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- only 12 animals used in the treatment group
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- Study conducted in 1993, no OECD Guidelines were available for LLNA at this date (OECD 429 firstly adopted in 2002)
- Species:
- guinea pig
- Strain:
- other: Bor:DHPW
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann, Borchen, Germany
- Age at study initiation: appr. 4-7 weeks
- Weight at study initiation: mean 320 g
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum):ad libitum
- Acclimation period: at least 7 days - Route:
- epicutaneous, occlusive
- Vehicle:
- propylene glycol
- Concentration / amount:
- 100% for induction
50 and 25% for first challenge
12 and 6% for second challenge
25% for second challenge - Route:
- epicutaneous, occlusive
- Vehicle:
- propylene glycol
- Concentration / amount:
- 100% for induction
50 and 25% for first challenge
12 and 6% for second challenge
25% for second challenge - No. of animals per dose:
- 12
- Details on study design:
- RANGE FINDING TESTS:
- concentrations of 12, 25, 50 and 100 % were tested
- occlusive treatment for 6 hours
- Evaluaton (hr after treatment): 24, 48 and 72 hours
- number of animals in the range finding test: 5/concentration
- result: no signs of irritation
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 3, separated by 7 days each
- Exposure period: 6 h occusive
- Test groups: 12 animals
- Control group: 12 animals
- Concentrations: 100 %
- Evaluation: 24 hours after each induction
- Result: slight skin erythema (grade 0.) after second (3 animals) and third (5 animals) induction.
B. CHALLENGE EXPOSURE
- No. of exposures: 2 (first and second challenge), epicutaneous treatment
- Day(s) of challenge: first challenge started 2 weeks after 3rd induction treatment, second challenge 7 days later
- Exposure period: 6 hours occlusive for each challenge
- Concentrations: 50 and 25 % for first challenge, 12 and 6 % for second challenge
- Evaluation (hr after challenge): 24, 48 and 72 hours after start of challenge
Reliability of the test system is routinely confirmed. - Challenge controls:
- yes: control group animals were treated in challenge experiments according to test group animals
- Positive control substance(s):
- not required
- Statistics:
- No data
- Positive control results:
- Routinely performed tests confirmed the sensitivity and reliability of the test system.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 1
- Total no. in group:
- 12
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50%. No with. + reactions: 1.0. Total no. in groups: 12.0. Clinical observations: none.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 2
- Total no. in group:
- 12
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50%. No with. + reactions: 2.0. Total no. in groups: 12.0. Clinical observations: none.
- Reading:
- 1st reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 4
- Total no. in group:
- 12
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 72.0. Group: test group. Dose level: 50%. No with. + reactions: 4.0. Total no. in groups: 12.0. Clinical observations: none.
- Reading:
- 1st reading
- Group:
- other: negative control group 24, 48 and 72 hours after challenge
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 12
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. Group: other: negative control group 24, 48 and 72 hours after challenge. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 12.0. Clinical observations: none.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 12
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 12.0. Clinical observations: none.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 4
- Total no. in group:
- 12
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25%. No with. + reactions: 4.0. Total no. in groups: 12.0. Clinical observations: none.
- Reading:
- 1st reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 5
- Total no. in group:
- 12
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 72.0. Group: test group. Dose level: 25%. No with. + reactions: 5.0. Total no. in groups: 12.0. Clinical observations: none.
- Reading:
- 1st reading
- Group:
- other: negative control group 24, 48, and 72 hours after challenge
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 12
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. Group: other: negative control group 24, 48, and 72 hours after challenge. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 12.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 12%
- No. with + reactions:
- 8
- Total no. in group:
- 12
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 24.0. Group: test group. Dose level: 12%. No with. + reactions: 8.0. Total no. in groups: 12.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 12%
- No. with + reactions:
- 8
- Total no. in group:
- 12
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 12%. No with. + reactions: 8.0. Total no. in groups: 12.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 12%
- No. with + reactions:
- 6
- Total no. in group:
- 12
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 12%. No with. + reactions: 6.0. Total no. in groups: 12.0. Clinical observations: none.
- Reading:
- 2nd reading
- Group:
- other: negative control group, 24, 48, and 72 hours after challenge
- Dose level:
- 12%
- No. with + reactions:
- 0
- Total no. in group:
- 12
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. Group: other: negative control group, 24, 48, and 72 hours after challenge. Dose level: 12%. No with. + reactions: 0.0. Total no. in groups: 12.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 6%
- No. with + reactions:
- 8
- Total no. in group:
- 12
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 24.0. Group: test group. Dose level: 6%. No with. + reactions: 8.0. Total no. in groups: 12.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 6%
- No. with + reactions:
- 8
- Total no. in group:
- 12
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 6%. No with. + reactions: 8.0. Total no. in groups: 12.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 6%
- No. with + reactions:
- 4
- Total no. in group:
- 12
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 6%. No with. + reactions: 4.0. Total no. in groups: 12.0. Clinical observations: none.
- Reading:
- 2nd reading
- Group:
- other: negative control group, 24, 48, and 72 hours after challenge
- Dose level:
- 6%
- No. with + reactions:
- 0
- Total no. in group:
- 12
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. Group: other: negative control group, 24, 48, and 72 hours after challenge. Dose level: 6%. No with. + reactions: 0.0. Total no. in groups: 12.0. Clinical observations: none.
- Parameter:
- SI
- Remarks on result:
- other: Not applicable
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Not applicable
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
- Conclusions:
- Under the test conditions, DESMODUR BL 3175 is classified as sensitising to the skin according to the criteria of the Annex VI to the Directive 67/548/EEC and the CLP Regulation (EC) N°( 1272-2008).
- Executive summary:
In a Buehler test, conducted according to the OECD 406 guideline in compliance with GLP, Desmodur BL 3175 was tested on 12 female Guinea pigs per group for its skin sensitizing properties . Concentrations of 100 (epicutaneous induction), 50 and 25% (first challenge) and 12 and 6% (second challenge) of the test material in propylene glycol were used.
Under the conditions, Desmodur BL 3175 was shown to exhibit a distinct skin sensitization potential.
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Well-conducted guideline study, GLP with no deviations
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Study conducted in 1995, no OECD Guidelines were available for LLNA at this date (OECD 429 firstly adopted in 2002)
- Species:
- guinea pig
- Strain:
- Himalayan
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: BRL Ltd, Basel
- Age at study initiation: 6 weeks
- Weight at study initiation: 274-421g
- Housing: 2 animals by metal cage with wire-mesh floors
- Diet (e.g. ad libitum): free access to standard guinea-pig diet including ascorbic acid (1600 mg/kg)
- Water (e.g. ad libitum): free access to tap water, diluted with decalcified water
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21°C
- Humidity (%): 50%
Fluctuations from these optimal conditions were noted, bt were considered not to have affected study integrity.
- Air changes (per hr): 15 airs changes per hour
- Photoperiod (hrs dark / hrs light): lighting was 12 hours artificial flurorescent light and 12 hours dark per day
IN-LIFE DATES: From: 08.23.1994 To: 09.23.1994 - Route:
- intradermal and epicutaneous
- Vehicle:
- propylene glycol
- Concentration / amount:
- INDUCTION - EXPERIMENTAL ANIMALS
- Intradermal induction: 0.5% in propylene glycol (w/w)
- Epidermal induction: undiluted test substance: 100% (w/w)
INDUCTION - CONTROL ANIMALS
Intradermally injected as similar to described above for the experimental animals without the test substance.
Epidermally treated with a dry patch.
CHALLENGE
- Challenge: 50, 25 and 10% in propylene glycol (w/w) - Route:
- epicutaneous, occlusive
- Vehicle:
- propylene glycol
- Concentration / amount:
- INDUCTION - EXPERIMENTAL ANIMALS
- Intradermal induction: 0.5% in propylene glycol (w/w)
- Epidermal induction: undiluted test substance: 100% (w/w)
INDUCTION - CONTROL ANIMALS
Intradermally injected as similar to described above for the experimental animals without the test substance.
Epidermally treated with a dry patch.
CHALLENGE
- Challenge: 50, 25 and 10% in propylene glycol (w/w) - No. of animals per dose:
- Preliminary study: 5 females
Experimental group: 10 females
Control group: 5 females - Details on study design:
- RANGE FINDING TESTS:
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 : intradermal and epidermal
- Exposure period: 48 hours for epidermal exposure
- Test groups:
- Control group:
- Site: in the clipped scapular region
- Frequency of applications: intradermal exposure on Day 1 and epidermal exposure on Day 8
- Duration:
- Concentrations: 0.5% in propylene glycol (w/w) for intradermal exposure and 100% of undiluted substance for epidermal exposure
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: Day 22
- Exposure period: 48 hours
- Test groups:
- Control group:
- Site: on the clipped and shaved flank
- Concentrations: 50, 25 and 10% in propylene glycol (w/w)
- Evaluation (hr after challenge): 24 and 48 hours &fter removal of the dressings
OTHER:
In addition to the skin reactions the following data were recorded:
- Mortality/Viability/Toxicity : Twice daily
- Body weight: Prior to start and at termination of the study - Positive control substance(s):
- yes
- Remarks:
- Alpha-Hexylcinnamidecaldehyde
- Statistics:
- No data
- Positive control results:
- The positive control experiment (most recent in July 1994) was carried out to check the sensitivity of the test system as used by NOTOX, in
accordance with the test method described in the report.
Concentrations selected for this study were:
- Intradermal induction: 5% solution in physiological saline (w/w)
- Epidermal induction: undiluted test substance: 100%
- Challenge: 10, 5, 2 and 0% solution in distilled water (w/w)
Taking into account the intensity if the skin reactions noted in the control animals, it was considered that positive reactions, indicative of sensitisation, were observed in all experimental animals in response to one or more of the test substance concentrations. These results lead to the maximum
sensitisation rate of 100%, which indicates that Alpha-Hexylcinnamidecaldehyde has extreme sensitising properties in this test applying the rating if
allergenicity described by Kligman A. M. (1996). (See table 7.4.1 a.)
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50% . No with. + reactions: 9.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 8
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25% . No with. + reactions: 8.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10%
- No. with + reactions:
- 7
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 10% . No with. + reactions: 7.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 50%. No with. + reactions: 9.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 8
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 72.0. Group: test group. Dose level: 25%. No with. + reactions: 8.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 10%
- No. with + reactions:
- 7
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 10%. No with. + reactions: 7.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 0%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 50%
- No. with + reactions:
- 2
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 50%. No with. + reactions: 2.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25%
- No. with + reactions:
- 1
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 25%. No with. + reactions: 1.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 10%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 0%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 50%
- No. with + reactions:
- 2
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: negative control. Dose level: 50%. No with. + reactions: 2.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: negative control. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 10%
- No. with + reactions:
- 0
- Total no. in group:
- 0
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: negative control. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 0.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 0
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: negative control. Dose level: 0%. No with. + reactions: 0.0. Total no. in groups: 0.0.
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
- Conclusions:
- Under the test conditions, DESMODUR BL 3175 is classified as sensitizing for the skin according to the criteria of the Annex VI to the Directive
67/548/EEC and to the criteria of the Annex I to the CLP Regulation (EC) N°( 1272-2008). - Executive summary:
In a sensitising study, performed according to the OECD guideline N°406 ( Maximization test of Magnusson and Kligman) in compliance with GLP, 10 females albino guinea-pig per doses were exposed to DESMODUR BL 3175 in a preliminary test in order to select the concentrations for the main study. The highest dose inducing skin irritation is 100% and the non-irritant highest dose is 50%, respectively used for induction and challenge in the main study.
Nine, eight and seven animals showed a skin reaction in response to the 50, 25 and 10% test substance concentrations in the main study, respectively.
Therefore, DEMSODUR BL 3175 is classified as a sensitising to the skin according to the criteria of the Annex VII to the Directive
67/548/EEC and to the criteria of the Annex I to the CLP Regulation (EC) N°( 1272-2008).
Referenceopen allclose all
The first challenge with the 50% and 25% test item formulation led to skin effects (slight to moderate) in 4/12 animals and 5/12 of the test item group, respectively. The second challenge with a 12% and 6% test item formulation led to skin effects (slight to moderate erythema and/or scale formation) in 9/12 animals (in one animal erythema was recognized after 48 and 72 hours only). In none of the control animals signs of skin reactions were seen. In summary, under the conditions of the Buehler test and with respect to the evaluation criteria the test item exhibits a distinct skin-sensitization potential.
PRELIMINARY STUDY (See Table 7.4.1 b.)
No signs of systemic toxicity were observed.
The test substance concentrations used in the main study were based on the findings in the preliminary study and in accordance with Magnusson and Kligman (1969).
The highest concentration inducing skin irritation used for induction is 100%
The non-irritant highest concentration is 50%.
MAIN STUDY - INDUCTION (See table 7.4.1 c.)
All experimental and control animals showed a marked area with necrosis and erythema around theses areas, 24 hours after the intradermal injections. Four experimental animals showed slight erythema after the 48 hours occluded epidermal induction exposure. The control animals showed no skin irritation.
MAIN STUDY - CHALLENGE
Control group: (See table 7.4.1 e.)
Two animals showed discrete or patchy erythema and scaliness in response to the 50% test substance and one of these two animals showed a similar skin reaction in response to the 25% concentration. No skin reactions were evident in response to the 10% concentration.
Exeprimental group: (See table 7.4.1 d.)
Nine, eight and seven animals of a total of nine experimental animals showed a skin reaction in response to 50%, 25% and 10% test substance concentrations, respectively. These reactions were characterised by redness (grade 1 and 2) and scaliness and in three animals eschar/crust formation (grade 4) in response to the 50% concentration.
TOXICITY Symptoms / MORTALITY
No mortality occured and no symptoms of systemic toxicity were observed in the animals of the main study during the study period.
However, one experimental animal (No.584) was killed in extremis on Day 14. One paw of this animal was jammed in the wire-mesh floor of the cage and had become severely injured.
BODY WEIGHTS
The average body weight gain of experimental and control animals was considered to be similar.
Table 7.4.1 a. Skin reactions to the challenges for positive control
|
Alpha-Hexylcinnamidecaldehyde |
|||
10% |
5% |
2% |
0% |
|
Number of experimental animals with skin reactions (scores varying 1-4) |
10 |
10 |
10 |
0 |
Number of control animals with skin reactions (scores 1 only) |
5 |
3 |
0 |
0 |
Number of positive reactions |
6 |
5 |
10 |
0 |
Sensitisation rate (%) |
60 |
50 |
100 |
0 |
Table 7.4.1 b.Scores observed from the challenge response in the preliminary test
Skin readings after bandage removal |
|||||
|
|
24h |
48h |
||
Animal No. |
Concentration % (w/w) |
erythema |
oedema |
erythema |
oedema |
595 |
100 50 25 10 |
1 0 0 0 |
0 0 0 0 |
1 0 0 0 |
0 0 0 0 |
596 |
100 50 25 10 |
1 0 0 0 |
0 0 0 0 |
0 0 0 0 |
0 0 0 0 |
597 |
100 50 25 10 |
2 1 0 0 |
0 0 0 0 |
2 0a 0 0 |
0 0 0 0 |
598 |
100 50 25 10 |
1 0 0 0 |
0 0 0 0 |
1 0 0 0 |
0 0 0 0 |
a = this site showed fissuring of the skin
Table 7.4.1 c.Challenge readings for experimental group
Experimental group |
|||||||||
|
|
Day 24 |
Day 25 |
||||||
Sex |
Animal number |
Readings |
Readings |
||||||
|
|
50 |
25 |
10 |
0 |
50 |
25 |
10 |
0 |
Female |
580 |
2 |
2 |
1 |
0 |
2s |
1s |
1s |
0 |
|
581 |
2 |
1 |
1 |
0 |
1s |
1 |
1 |
0 |
|
582 |
1 |
1 |
0 |
0 |
2s |
1s |
0s |
0 |
|
583 |
4 |
2 |
1 |
0 |
4ks |
2s |
2s |
0 |
|
584 |
- |
- |
- |
- |
- |
- |
- |
-b |
|
585 |
4k |
2 |
2 |
0 |
4ks |
1s |
1s |
0 |
|
586 |
1 |
0 |
0 |
0 |
1s |
0 |
0 |
0 |
|
587 |
4k |
1 |
2 |
0 |
4k |
1 |
1 |
0 |
|
588 |
1 |
1 |
1 |
0 |
1s |
1 |
1 |
0 |
|
589 |
1 |
1 |
1 |
0 |
1 |
1 |
1 |
0 |
s = this site also showed scaliness
k = this site also showedeschar/crust formation
b = this animal was killed in extremis on Day 14
Table 7.4.1d.Challenge readings for control group
Control group |
|||||||||
|
|
Day 24 |
Day 25 |
||||||
Sex |
Animal number |
Readings |
Readings |
||||||
|
|
50 |
25 |
10 |
0 |
50 |
25 |
10 |
0 |
Female |
590 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
591 |
1 |
0 |
0 |
0 |
1s |
0 |
0 |
0 |
|
592 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
593 |
1 |
1 |
0 |
0 |
1s |
0 |
0 |
0 |
|
594 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
s = this site also showed scaliness
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
In a dermal sensitization study , performed according to the OECD 406 guideline (Maximization test of Magnusson and Kligman) (Daamen P.A.M., 1995) in compliance with GLP, 10 female guinea-pigs per dose were exposed to DESMODUR BL 3175 in propylene glycol.A preliminary test has been performed in order to select the concentrations for the main study. The highest concentration inducing skin irritation is 100% and the non-irritant highest concentrations is 50%. Therefore, the concentration used for induction is 100% and 50, 25 and 10% respectively for induction and challenges.
Nine, eight and seven animals showed skin reaction in response to the 50, 25 and 10% concentrations in the main study, respectively.
Migrated from Short description of key information:
In a dermal sensitization study with DESMODUR BL 3175 in propylene glycol, performed according to the OECD 406 guideline, in compliance with GLP
dermal reactions were observed in more than 30% of the animals tested for the three concentrations challenged.
Thus DESMODUR BL 3175 is classified as sensitising to the skin according to the criteria of the Annex VI to the Directive 67/548/EC and to the
criteria of the Annex I to the CLP Regulation N° (1272/2008).
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
No data
Justification for classification or non-classification
As dermal reactions were seen during the three challenges in more than 30% of the animals (9/10 for 50%, 8/10 for 25 and 7/10 for 10% respectively test item formulation), in a dermal sensitization study performed according to guideline OECD 406 in compliance with GLP, DESMODUR BL 3175 (75% HDI Trimer MEKO blocked in 25% of solvent naphta 100) is classified as sensitising to the skin according to the criteria of the Annex VI to the Directive 67/548/EC and to the criteria of the Annex I to the CLP Regulation N° (1272/2008).
According to an expert judgment, HDI Trimer MEKO blocked is classified as a sensitiser to the skin by default as the solvent is not sensitising and as the preparation contains about 75% of test substance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.